Alzprotect: Positive Feedback From the EMA and FDA on Alzprotect's Phase 2b/3 Development Strategy for PSP

ALZPROTECT is thrilled to announce that it has received favorable feedback from both the American (FDA) and European (EMA) authorities regarding the regulatory path for advancing the clinical deve...